• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Vertex Pharmaceuticals

Vertex Pharmaceuticals

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. UPDATE: Five reasons you have to buy biotech stocks now

    UPDATE: Five reasons you have to buy biotech stocks now

  2. UPDATE: Five reasons you have to buy biotech stocks now

    UPDATE: Five reasons you have to buy biotech stocks now

  3. BIO Elects John Maraganore, Ph.D., as New Chair

    BIO Elects John Maraganore, Ph.D., as New Chair

  4. Vertex Announces Nine Presentations of Data on ORKAMBI® (lumacaftor/ivacaftor) and KALYDECO® (ivacaftor) at the European Cystic Fibrosis Society (ECFS) Conference

    Vertex Announces Nine Presentations of Data on ORKAMBI® (lumacaftor/ivacaftor) and KALYDECO® (ivacaftor) at the European Cystic Fibrosis Society (ECFS) Conference

  5. Vertex Announces Long-Term Reimbursement Agreement with the Republic of Ireland for ORKAMBI® (lumacaftor/ivacaftor), KALYDECO® (ivacaftor) and Future Cystic Fibrosis Medicines

    Vertex Announces Long-Term Reimbursement Agreement with the Republic of Ireland for ORKAMBI® (lumacaftor/ivacaftor), KALYDECO® (ivacaftor) and Future Cystic Fibrosis Medicines

  6. Vertex to Present at the Goldman Sachs Healthcare Conference on June 13

    Vertex to Present at the Goldman Sachs Healthcare Conference on June 13

  7. UPDATE: 20 big winners in the S&P 500 this earnings season

    UPDATE: 20 big winners in the S&P 500 this earnings season

  8. UPDATE: 20 big winners in the S&P 500 this earnings season

    UPDATE: 20 big winners in the S&P 500 this earnings season

  9. UPDATE: 20 big winners in the S&P 500 this earnings season

    UPDATE: 20 big winners in the S&P 500 this earnings season

  10. UPDATE: 20 big winners in the S&P 500 this earnings season

    UPDATE: 20 big winners in the S&P 500 this earnings season

123

©2017 Morningstar Advisor. All right reserved.